Allen I Konno

Title: The Innovative Contributions of Allen I. Konno

Introduction

Allen I. Konno, an inventor based in Kailua-Kona, Hawaii, has made significant strides in the field of health and wellness through his innovative patent. With a keen focus on utilizing chitin and chitosan oligosaccharides, he has developed a method that aims to prevent and treat common ailments, particularly the common cold.

Latest Patents

Konno holds a notable patent involving chitin oligosaccharides and/or chitosan oligosaccharides, which are designed to prevent or treat the common cold as well as alleviate pain in mammals, including humans. His invention consists of a method that leverages a water-soluble mixture available in oral form. The active ingredients indicated in this patent comprise a variety of chitin oligomers, including di N-acetyl chitobiose, tri N-acetyl chitotriose, tetra N-acetyl chitotetraose, penta N-acetyl chitopentaose, and hexa N-acetyl chitohexaose, among others. This innovative approach is significant in addressing both viral infections and pain management.

Career Highlights

Working with JDC (Hawaii) Inc., Konno has demonstrated a strong commitment to research and innovation in the healthcare sector. His ability to merge scientific research with practical applications is reflected in his patent, showcasing his contribution to improvements in wellness solutions. The success of his invention underlines the importance of continuous innovation in the health industry.

Collaborations

Throughout his career, Allen has collaborated with notable colleagues such as Jay H. Gauthier and Yoshiharu Matahira. These partnerships have likely enriched his research endeavors and contributed to further developments in the field of health sciences.

Conclusion

Allen I. Konno's contributions to the field of health through his innovative patent on chitin oligosaccharides exemplify the role of inventors in advancing medical solutions. His work not only seeks to improve the prevention and treatment of common colds but also demonstrates the potential for pain management in mammals. As he continues to work with JDC (Hawaii) Inc., his future innovations may pave the way for significant advancements in healthcare.